因塞特医疗公司 (Incyte Corp) 于1991年在特拉华州注册成立。公司是一家生物制药公司，专注于专利小分子药物的发现、开发和商业化，以治疗严重未满足的医疗需求。
中文介绍: https://xueqiu.com/S/INCY
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). Incyte's pipeline includes a broad array of oncology and dermatology programs.
英文介绍: https://www.morningstar.com/stocks/xnas/incy/quote
主题测试文章，只做测试使用。发布者：star，转转请注明出处：https://wallstreetgm.com/incy-incyte-corp-%e5%9b%a0%e5%a1%9e%e7%89%b9%e5%8c%bb%e7%96%97%e5%85%ac%e5%8f%b8/
